Compositions and methods for managing nephropathy
AssigneeSami-Sabinsa Group Limited
InventorsMuhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani, Anjali Pandey
Life of this patent
Estimating the term…
Loading patent…
AssigneeSami-Sabinsa Group Limited
InventorsMuhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani, Anjali Pandey
Estimating the term…
The invention discloses the use of a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids in the therapeutic management of nephropathy in mammals. The composition further comprises β-glucogallin and total mucic acid gallates, C-glucosides and tannins isolated from Pterocarpus marsupium. The invention also discloses the potential of the composition comprising β-glucogallin and total mucic acid gallates from Emblica officinalis, C-glucosides and tannins isolated from Pterocarpus marsupium in the therapeutic management of nephropathy.
A method for the therapeutic management of nephropathy in mammals, said method comprising step of administering a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids to mammals in need of such therapeutic management.
A method for the maintaining normal kidney function in mammals, said method comprising step of administering a composition comprising 70%-80% w/w tetrahydrocurcuminoids, 10%-20% w/w hexahydrocurcuminoids and 5%-10% w/w octahydrocurcuminoids to mammals in need of such effect.
A method for the therapeutic management of nephropathy in mammals, said method comprising step of administering a composition comprising at least 10% w/w 1-O-galloyl-β-D-glucose (β-glucogallin) and at least 10% w/w total mucic acid gallates and ellagic acid, isolated from Emblica officinalis and Pterocarpus marsupium extract standardized to contain tannins and C-glycosides containing not less than 0.5% w/w Pterocarposide, not less than 0.5% w/w Sabioside, to mammals in need of such therapeutic management.
A method for the maintaining normal kidney function in mammals, said method comprising step of administering a composition comprising at least 10% w/w 1-O-galloyl-β-D-glucose (β-glucogallin) and at least 10% w/w total mucic acid gallates and ellagic acid, isolated from Emblica officinalis and Pterocarpus marsupium extract standardized to contain tannis and C-glycosides containing not less than 0.5% w/w Pterocarposide, not less than 0.5% w/w Sabioside, to mammals in need of such effect.
Dependencies are inferred from the claim text.